CVD data to be standardized across Europe

March 04, 2013

Sophia Antipolis, Monday 4 March 2013: Budgets are becoming tighter and health systems are under pressure to address the increasing burden of chronic diseases. Tackling chronic diseases requires up to date information on disease prevalence and risk factors but Europe currently lacks data on cardiovascular disease (CVD) that is standardized and can be compared.

The European Society of Cardiology (ESC) is therefore creating a task force on CVD data standardization so that data from different registries can be compared. The ESC will also collaborate with the PAtient REgistries iNiTiative (PARENT) Joint Action (1) to create an inventory of registries - this will help the cardiology community find existing data and avoid duplication.

The moves follow a meeting of cardiology organizations and experts initiated by the ESC in Brussels, Belgium, to discuss the need for coordination and standardization of CVD data in Europe (2).

The ESC task force on CVD data standardization will build on Cardiology Audit and Registration Data Standards (CARDS). ESC experts were instrumental in CARDS, which was an initiative of the Irish Ministry of Health & Children and co-funded by the European Union (EU) in 2004. CARDS aimed to standardize the definitions used in the collection of CVD data, and resulted in three data sets for three sub-specialties of cardiology: percutaneous coronary intervention, clinical electrophysiology and acute coronary syndromes.

Professor Frans Van de Werf (Leuven, Belgium), who was the instigator of the Brussels workshop, said: "CARDS is nearly 10 years old and should be updated. We need to get more countries and studies involved in implementing it so that everyone can benefit from standardized, comparable data on cardiovascular disease."

Professor Van de Werf said: "The inventory of registries will provide a single entry point for health professionals, researchers and policy makers looking for real life data on cardiovascular diseases. It will also avoid duplication of data collection in Europe. Countries will be able to use country-level data from European registries, rather than establishing their own registry. This will save valuable time and money."
-end-
Notes to editor

(1) Joint Actions are projects carried out by the European Union (EU) and one or more Member States or by the EU and the competent authorities of other countries participating in the health programme.

The PARENT Joint Action was established to support cross-border use of patient registry data for public health and research purposes including health technology assessment, pricing, and vigilance and safety. It brings support to EU member states for the development and governance of patient registries.

(2) The meeting was attended by:

British Heart Foundation Health Promotion Research Group (BHFHPRG), University of Oxford (UK)

European Commission, DG SANCO (Belgium)

European Heart Network (Belgium)

European Organisation for Research & Treatment of Cancer (Belgium)

European Organisation for Research and Treatment of Cancer (EORTC) (Belgium)

European Society of Cardiology (France)

National Institute for Health & Welfare (Finland)

National Institute of Public Health (Slovenia)

Organisation for Economic Co-operation and Development (OECD)

Universities of Ghent and Brussels (Belgium)

About the European Society of Cardiology

The European Society of Cardiology (ESC) represents more than 80,000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.

European Society of Cardiology

Related Cardiovascular Disease Articles from Brightsurf:

Changes by income level in cardiovascular disease in US
Researchers examined changes in how common cardiovascular disease was in the highest-income earners compared with the rest of the population in the United States between 1999 and 2016.

Fighting cardiovascular disease with acne drug
Researchers from the European Molecular Biology Laboratory (EMBL) in Heidelberg and Stanford University have found the cause of dilated cardiomyopathy - a leading cause of heart failure - and identified a potential treatment for it: a drug already used to treat acne.

A talk with your GP may prevent cardiovascular disease
Having a general practitioner (GP) who is trained in motivational interviewing may reduce your risk of getting cardiovascular disease.

Dilemma of COVID-19, aging and cardiovascular disease
Whether individuals should continue to take angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the context of coronavirus disease 2019 (COVID-19) is discussed in this article.

Air pollution linked to dementia and cardiovascular disease
People continuously exposed to air pollution are at increased risk of dementia, especially if they also suffer from cardiovascular diseases, according to a study at Karolinska Institutet in Sweden published in the journal JAMA Neurology.

New insights into the effect of aging on cardiovascular disease
Aging adults are more likely to have - and die from - cardiovascular disease than their younger counterparts.

Premature death from cardiovascular disease
National data were used to examine changes from 2000 to 2015 in premature death (ages 25 to 64) from cardiovascular disease in the United States.

Ultrasound: The potential power for cardiovascular disease therapy
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 2, pp.

Despite the ACA, millions of Americans with cardiovascular disease still can't get care
Cardiovascular disease (CVD) is the leading cause of death for Americans, yet millions with CVD or cardiovascular risk factors (CVRF) still can't access the care they need, even years after the implementation of the Affordable Care Act (ACA).

Excess weight and body fat cause cardiovascular disease
In the first Mendelian randomization study to look at this, researchers have found evidence that excess weight and body fat cause a range of heart and blood vessel diseases (rather than just being associated with it).

Read More: Cardiovascular Disease News and Cardiovascular Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.